Repaglinide Medications

Repaglinide Info

What is Repaglinide?

Repaglinide is an oral blood-sugar-lowering medicine that belongs to the class of rapid-acting insulin secretagogues. It helps the pancreas release a short burst of insulin after meals. In the United Kingdom, repaglinide is available under the brand name Prandin and as a generic tablet.

Medications with Repaglinide

The main product containing repaglinide is Prandin, marketed by Novo Nordisk. It is supplied as immediate-release tablets in strengths of 0.5 mg, 1 mg and 2 mg. Generic versions of repaglinide are also authorised by the MHRA and can be found in most community pharmacies. All formulations are taken by mouth, either as a plain tablet or as part of a combination pack that includes other diabetes medicines. Availability may vary across the UK, but both brand-name and generic repaglinide tablets are widely prescribed for type 2 diabetes.

What Does Repaglinide Treat?

Repaglinide is prescribed to help control blood glucose in people with type 2 diabetes mellitus. It is especially useful for:

• Post-meal (postprandial) blood-sugar spikes - the drug works quickly to curb the rise in glucose that follows a meal.
• Overall glycaemic management - when used alongside diet and exercise, it contributes to keeping average blood-sugar levels within target ranges.
• Adjunct therapy - repaglinide can be added to other oral agents or insulin when a single medication does not achieve adequate control.
• Situations requiring flexible dosing - because its effect lasts only a few hours, the dose can be adjusted for each meal, making it suitable for irregular eating patterns.

These uses are approved by the MHRA for adults with type 2 diabetes. Any other application would be considered off-label and should be discussed with a healthcare professional.

How Repaglinide Works

Repaglinide prompts the beta cells in the pancreas to release a short, rapid surge of insulin when food is eaten. By increasing insulin only around mealtime, it helps lower the glucose that enters the bloodstream after a meal without causing prolonged insulin exposure. The tablet begins to act within about 15-30 minutes, peaks in roughly an hour, and its effect wanes after 3-4 hours. This quick onset allows the dose to be matched to individual meals.

Safety Information

Common Side Effects

Most people experience only mild, temporary reactions such as:

• Feeling light-headed or dizzy, especially if a meal is missed.
• Nausea or mild stomach upset.
• Headache.

These symptoms usually resolve on their own and are not a reason to stop treatment without professional guidance.

Serious Reactions

Although rare, some reactions need urgent medical attention:

• Severe allergic signs, like swelling of the face, lips or tongue, or rash that spreads quickly.
• Signs of low blood sugar (hypoglycaemia) that are hard to reverse, such as confusion, loss of consciousness or seizures.
• Unexplained fast heartbeat or difficulty breathing.

If any of these occur, seek immediate help from emergency services.

Who Should Be Cautious

People with the following conditions should discuss repaglinide use with a clinician before starting:

• Severe liver disease, as the drug is processed mainly by the liver.
• Uncontrolled infection or serious illness that may affect blood-sugar control.
• Known allergy to repaglinide or any component of the tablet.

Pregnant or breastfeeding women are advised to avoid repaglinide unless a doctor determines the benefit outweighs the risk.

Interaction Awareness

Repaglinide may interact with several drug groups:

• Other diabetes medicines that also stimulate insulin release can increase the risk of hypoglycaemia.
• Certain antibiotics (e.g., clarithromycin) and antifungal agents may raise repaglinide levels.
• Alcohol can enhance the blood-sugar-lowering effect and should be consumed cautiously.

Lifestyle factors such as skipping meals, excessive alcohol, or sudden changes in diet can also affect how the medication works. For a full interaction list, refer to the individual product information for each repaglinide medication.

What to Know Before Using

Store repaglinide tablets in a cool, dry place away from direct sunlight and keep them out of reach of children. The tablets are intended for short-term use around meals, but some patients may require longer periods under medical supervision. Because each repaglinide product (e.g., Prandin versus a generic tablet) may have different strengths, always follow the instructions that come with the specific medication you have. For detailed usage, dosing, and administration, refer to the patient leaflet supplied with your particular product.

Key Terms

Postprandial: Relating to the period after eating a meal.

Hypoglycaemia: A condition where blood-sugar levels fall below normal, causing symptoms such as shakiness, sweating, or confusion.

Insulin secretagogue: A drug that stimulates the pancreas to release insulin.

Important Notice

This article offers general educational information about repaglinide as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing repaglinide may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.